EQL PHARMA AB (7JK) — Financial Flexibility Index
EQL PHARMA AB (7JK) has a Financial Flexibility Index of 0.05x as of December 2025. Free cash flow of €25.32 Million (operating CF €13.44 Million minus capex €11.87 Million) represents 0% of total liabilities (€543.76 Million). Also explore EQL PHARMA AB annual equity growth to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
EQL PHARMA AB Financial Flexibility Index (2022–2025)
Historical Financial Flexibility Index trend for EQL PHARMA AB across 4 annual periods. See debt-free asset ratio of EQL PHARMA AB to measure how much of total assets are equity-financed.
Annual Financial Flexibility Index for EQL PHARMA AB (2022–2025)
Year-by-year free cash flow to debt coverage for EQL PHARMA AB. For the full company profile including market capitalisation, see EQL PHARMA AB (7JK) total market value.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.38x | €221.19 Million | €-24.65 Million | €587.79 Million | ▲ +34.6% |
| 2024 | 0.28x | €54.83 Million | €-11.44 Million | €196.03 Million | ▼ -23.9% |
| 2023 | 0.37x | €48.12 Million | €27.62 Million | €130.94 Million | ▼ -34.3% |
| 2022 | 0.56x | €63.92 Million | €41.83 Million | €114.26 Million | — |